The reimbursement of COVID-19 PCR testing to be reduced in Germany

26

Jun 2020

The reimbursement for PCR tests for the detection of SARS-CoV-2 will be reduced from €59.00 to €39.40 per test beginning from July 1, 2020, and the billing of the examination will be limited to five times in the case of treatment. This decision was made by the extended evaluation committee on June 10, 2020.

The laboratory test for SARS-CoV-2 can be performed and calculated by specialists for laboratory medicine or microbiology, virology, and infectious disease epidemiology.

For this purpose, a new fee order item (GOP) was added to the EBM on February 1, 2020: 32816 “Detection of the beta-coronavirus SARS-CoV-2 nucleic acid using RT-PCR including a confirmation test for reactivity in the search test (report of findings within 24 hours after submission of material)” (Nukleinsäurenachweis des beta-Coronavirus SARS-CoV-2 mittels RT-PCR einschließlich eines Bestätigungstestes bei Reaktivität im Suchtest (Befundmitteilung innerhalb von 24 Stunden nach Materialeinsendung)). The GOP 32816 was previously valued at €59.00 per PCR test and will now be reduced to €39.40 starting from July 1, 2020. Costs for the material shipping and transporting can be calculated in addition to other special laboratory services.

The cost of the PCR test when billing according to the fee schedule for doctors (GOÄ) stays unchanged and amounts ca. €120.

The full details in German can be found here.

The full list of COVID-19 tests presented on the German market as of June 12, 2020, can be found here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

05

Dec 2022

On November 17, 2022, the Ministry of Health and Prevention published the Order in the Official Journal of the French Republic on the extension of the national newborn screening by laboratory diagnostics to seven more diseases (inborn errors of metabolism).

Read more

02

Dec 2022

On November 15, 2022, a new body called “Organization for Outpatient Physician Tariffs AG (OAAT)” was founded under the leadership of the Bernese government councillor. It involves all tariff partners (associations of health insurers curafutura and santésuisse, as well as the association of hospitals H+, the association of physicians FMH, and medical tariff commission MTK/CTM), who have joined forces in order to reach the goal of improving the outpatient reimbursement system.

Read more

30

Nov 2022

In November 2022, the National Board of Health and Welfare released the Swedish version of the NordDRG system to come into force in January 2023, including the list of DRG codes, names, and cost-weights. A total of 77 new DRGs will be implemented. Key new DRGs were introduced in cardiovascular, gastrointestinal, and endoscopy fields, also for breast reconstruction and bone-anchored hearing implants.

Read more

29

Nov 2022

On November 18, 2022, the Innovation Committee at the Federal Joint Committee (G-BA) announced that sixteen applications for Innovation Funding of the new forms of care were accepted. These applications relate to the funding announcement of March 17, 2021. Most projects relate to interdisciplinary or cross-sectoral care and pathways.

Read more

28

Nov 2022

The new version of the classification of procedure codes (CCAM v.71), applicable from December 03, 2022, was published in France. Several changes were introduced, including the creation of four new codes related to ENT, pulmonary and airways, and interventional radiology areas. Also, the modification of tariffs for 50 dental procedure codes will enter into force on January 01, 2023.

Read more